Confirmatory testing in primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 5, 2012, Pages 1688-1694

  Nanba, Kazutaka ^a   Tamanaha, Tamiko ^a   Nakao, Kanako ^a   Kawashima, Sachiko Tsukamoto ^a   Usui, Takeshi ^a   Tagami, Tetsuya ^a   Okuno, Hiroshi ^a   Shimatsu, Akira ^a   Suzuki, Tomoko ^b   Naruse, Mitsuhide ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CAPTOPRIL; FUROSEMIDE; HYDROCORTISONE; POTASSIUM; RENIN; SODIUM CHLORIDE; TETRACOSACTIDE;

ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HYPERTENSION; HYPOKALEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADRENAL GLANDS; ADULT; AGED; ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD COMPONENT REMOVAL; CAPTOPRIL; FEMALE; FUROSEMIDE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84860768775     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2504     Document Type: Article

References (31)

1. Kaplan NM 1967 Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med 66:1079-1090
2. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW 1987 Secondary hypertension in a blood pressure clinic. Arch Intern Med 147:1289-1293
3. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-1593
4. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050
5. Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, Conlin PR 2006 Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens 20:129-136
6. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318
7. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM 2000 High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14:311-315
8. Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE 2003 Primary aldosteronism and hypertensive disease. Hypertension 42:161-165
9. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol 48:2293-2300
10. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P 2002 Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892-896
11. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248
12. Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T 1995 Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan. J Endocrinol Invest 18:370-373
13. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232-238
14. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatmentof patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
15. Young WF 2007 Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618
16. Rossi GP, Seccia TM, Pessina AC 2008 Primary aldosteronism. Part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21:447-454
17. Rossi GP, Seccia TM, Pessina AC 2008 Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21:455-462
18. Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, Stewart PM 2005 Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends in Endocrinology and Metabolism 16:114-119
19. Young Jr WF 2007 Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. Rev Endocr Metab Disord 8:309-320
20. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H 2009 The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32:3-107
21. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A 2011 Guidelines for the diagnosis and treatment of primary aldosteronism. The Japan Endocrine Society 2009. Endocr J 58:711-721
22. Castro OL, Yu X, Kem DC 2002 Diagnostic value of the postcaptopril test in primary aldosteronism. Hypertension 39:935-938
23. Agharazii M, Douville P, Grose JH, Lebel M 2001 Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37:1440-1443
24. Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F 2002 High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15:896-902
25. Omura M, Nishikawa T 2006 [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism]. Rinsho Byori 54:1157-1163 (Japanese)
26. Kem DC, Weinberger MH, Mayes DM, Nugent CA 1971 Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128:380-386
27. Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez-Sanchez CE 1984 Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6:717-723
28. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M 2006 Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 91:2618-2623
29. Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML 1983 Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 57:892-896
30. Mulatero P, Bertello C, Garrone C, Rossato D, Mengozzi G, Verhovez A, Fallo F, Veglio F 2007 Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50:e26-e27
31. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F 2007 Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50:424-431